The aim of this study was to investigate the association between diastolic dysfunction and long-term occurrence of new-onset atrial fibrillation (AF) and cardiac events in patients with acute myocardial infarction (AMI) and left ventricular (LV) systolic dysfunction.
Introduction
In retrospective studies, diastolic dysfunction has been found to be associated with the development of atrial fibrillation (AF) 1,2 and with major cardiovascular events (MACE) such as congestive heart failure, stroke, acute myocardial infarction (AMI), and cardiac death. 3 In patients with previous myocardial infarction, diastolic dysfunction is associated with a higher risk of cardiac death independent of left ventricular (LV) systolic function. 4 The association between AF and diastolic dysfunction in the early phase after an acute MI has been previously shown, 5, 6 but trials with systematic prospective follow-up of patients with diastolic dysfunction concerning AF are lacking. The CARISMA study enrolled patients with a recent MI and LV systolic dysfunction. The patients were implanted with an implantable loop recorder (ILR) (Reveal Plusw, Medtronic, Inc.) and followed for 2 years allowing continuous monitoring and diagnosis of asymptomatic and symptomatic arrhythmias. The aim of this study was to investigate the relation of LV diastolic dysfunction to new-onset AF and to MACE in the CARISMA population.
Methods Population
This study was performed on a subgroup of the CARISMA study population, described in detail elsewhere. 7 In the CARISMA study, 312
patients with an LV ejection fraction of 40% or less were included in 10 Scandinavian centres within 2 -5 days after experiencing an acute MI. Of these, 297 were implanted with an insertable loop recorder (ILR) (Reveal Plus, Medtronic, Inc.) within 21 days after enrolment, and were followed for 2 years at 3-month intervals. In patients enrolled at the Danish centres, the echocardiographic protocol performed at week 6 after MI was extended to include assessment of the LV diastolic function using tissue Doppler echocardiography. Of 88 patients enrolled at the two Danish centres, 26 patients were excluded for the following reasons: one patient died and three patients were excluded between enrolment and week 6, one patient was excluded due to presence of artificial mitral valve implant, seven patients did not have the extended echocardiogram performed for logistic reasons at week 6, and in nine patients one or more of the measurements required for grading of diastolic function was not useful for analysis due to poor acoustic window. Two patients were excluded, because they were in AF during the recording of the echocardiogram. If patients had a history of AF or developed AF before week 6, they were excluded from the analyses regarding risk for new-onset AF, but not for analyses regarding MACE.
Echocardiography
The echocardiograms were obtained on HP sonogram 4500 equipment by experienced investigators and stored on optical discs for offline analysis. All echocardiograms were performed in left decubitus position. All echocardiographic data were analysed after study termination using GE Echopac version 6.3 (GE Healthcare) by a skilled interpreter blinded to the patient outcome. Left atrial diameter and LV wall sizes were measured using M-mode from the parasternal window. LV systolic function was measured using the 16-segment wall motion index model. 8 Pulsed-wave Doppler (PWD) spectrograms were recorded with the area of interest at the level of the mitral valve tips. The peak diastolic myocardial velocity (E ′ ) was measured using pulsed-wave tissue Doppler (PWTD) with the area of interest placed in the mitral annulus in the lateral and septal wall. The average of these two measurements was used. The E/A ratio was measured as the ratio of the peak mitral early to late inflow velocity from PWD. Deceleration time (DT) was measured using the upper one-third of the descending slope of the early mitral inflow. The isovolumetric relaxation time (IVRT) was measured from PWD spectrograms by placing the area of interest between the mitral valve and the aortic valve. IVRT was defined as the time interval between closing of the aortic valve and opening of the mitral valve. The gradation of diastolic dysfunction was pre-specified 9 to be based on a combined assessment of E ′ , DT, E/A ratio, and IVRT. The gradation is shown in Table 1 .
Implantable loop recorder implantation and patient follow-up
The ILR was implanted between 3 and 21days after the AMI. If a pacemaker (PM) or implantable cardioverter defibrillator (ICD) was implanted later, the device was programmed to store arrhythmias at the same criteria as the ILR and was used for diagnosis of arrhythmias. The ILR is capable of storing 13 automatic recorded events, each lasting 2 min, and one manually recorded event lasting 14 min. To reduce detection of sinus rhythm, the ILR was programmed to be triggered by (i) bradycardia with heart rate slower than 30 bpm; (ii) a pause longer than 4.5 s; or (iii) tachycardia with a heart rate higher than 125 bpm. The patients were seen for follow-up every 3 months where the ILR was interrogated and a full medical history was obtained. The electrograms were stored on disc for later analysis. Every recorded event was classified by the investigator at each centre at the time of interrogation and adjudicated blinded by a member of the Steering Committee.
Endpoints
AF was defined as an episode of irregular tachycardia with no visible P-waves on the ECG documented by the ILR lasting more than 16 beats. In a pilot study on the CARISMA population, the ILR detected 70% of all tachyarrhythmias. 10 MACE were defined as re-infarction, stroke, or cardiovascular death, whichever occurred first.
Statistics
Baseline variables among subjects with normal filling patterns vs. subjects with abnormal filling patients were compared using t-test, Wilcoxon rank-sum test, x 2 test, and Fisher's exact test where appropriate. Pre-specified variables (age . 70, NYHA class and hypertension) and significant clinical baseline variables, defined as a P-value of 0.1 or less in the baseline comparison, were adjusted for in the multivariate analysis. The influence of each covariate on the variable of interest was tested using univariate and multivariate Cox proportional hazard regression analysis. The multivariate Cox models were constructed by adding and removing the additional covariates one at a time while testing for effect on diastolic dysfunction and for interactions. As no baseline variables were predictive for either outcome or did affect the influence of diastolic dysfunction, only the pre-specified covariates are shown and only the univariate values are reported. The Kaplan-Meier estimator and the log-rank test were used for graphic display of non-time-dependent covariates. All analyses were performed using SAS 9.1.3 for Windows (SAS Institute, Inc., Cary, NC, USA).
Results Population
Sixty-two patients were included in this study. After analyses of the echocardiograms, 38 patients (61%) were classified as having normal LV filling patterns and 24 (39%) were diagnosed with abnormal LV filling pattern. The baseline characteristics of the two groups are shown in Table 2 . Patients with diastolic dysfunction were significantly older than patients with normal diastolic function, and trended towards a higher incidence of hypertension, symptomatic heart failure (NYHA class ≥ 2) and left-and right bundle branch block in the ECG. The initial device implanted was an ILR in 59 patients, PM in two patients, and an ICD in one patient. During the trial, additional 2 patients received a PM and 11 patients received an ICD. The medical treatment was optimized and balanced in the two groups at week 6. Four patients stopped beta-blockers, whereas one patient initiated and continued amiodarone treatment during the study, no other anti-arrhythmic drugs were used.
Atrial fibrillation
Three patients had a history of AF before enrolment into the study. Nine patients, five with normal diastolic function and four with diastolic dysfunction, developed AF in the 6 weeks between the AMI and the echocardiography. Figure 2 ). Age . 70 years, NYHA class, hypertension, and time-dependent AF were not univariate or multivariate risk factors for MACE.
Discussion
Diastolic dysfunction in post-MI patients with depressed LV systolic function was associated with a high risk of new-onset AF and of MACE such as re-infarction, stroke, and cardiovascular death.
Atrial fibrillation and diastolic dysfunction
This study is the first to show that new-onset AF developed significantly more frequent in patients with diastolic dysfunction, which is in coherence with previous retrospective reports on diastolic dysfunction and risk of AF. 1, 3, 5, 11, 12 However, as diastolic dysfunction is correlated with increased atrial pressures, 13 but AF in itself causes an increased left atrial pressure and diastolic dysfunction, the temporal association between AF and diastolic dysfunction has remained unclear. In this study, we show that development of new-onset AF after hospital discharge in patients with the acute MI is often preceded by previous or newly developed diastolic dysfunction.
The CARISMA study was the first study to describe the incidence of symptomatic and asymptomatic arrhythmias using continuous monitoring with an implantable cardiac monitor in post-MI patients with LV systolic dysfunction. This resulted in a much higher incidence of AF than in previous trials using conventional 12-lead ECG at clinical follow-ups to diagnose AF. 14, 15 Although results from the CARISMA study likely represents a closer estimate of the true incidence of AF in this population, future trials are needed to establish the clinical significance and management of short asymptomatic paroxysms of AF. Also, AF was defined as lasting ≥16 beats independent of the temporal duration, frequency, and symptomatology of the event. In the current guidelines, a clinical AF event is defined as lasting ≥30 s, but this definition is not based on clinical data. In this study, 10 of 15 patients experienced events lasting longer than 30 s, whereas 5 patients only experienced AF events lasting shorter than 30 s. As no former studies have been performed using continuous monitoring with an ILR, and the true clinical significance of short AF events ,30 s remains unknown, we decided to include all patients with AF. However, the results of this study should be interpreted in the light of the unknown clinical significance of shortlasting AF events.
Diastolic dysfunction and major cardiovascular events
LV diastolic dysfunction has been identified as a major predictor for cardiovascular death in several previous trials. 16 However, in many of these trials, diastolic dysfunction was defined as a restrictive pattern corresponding to grade 3 in the definitions used in this study. 4, 17, 18 In the CARISMA study, one of the enrolment criteria was an expected survival of at least 2 years. Thus, patients were generally less symptomatic at time of inclusion and most patients with diastolic dysfunction were categorized as grade 1. Accordingly, there were relatively few death events and most of the increased risk could be explained by a larger proportion of re-AMI and stroke among patients with diastolic dysfunction. The risk of ischaemic event and diastolic dysfunction has not been addressed directly in former trials. A previous study on post-MI patients with and without diastolic dysfunction found no correlation between several blood factors important to coagulation and diastolic function, but did report that diastolic dysfunction was associated with Doppler flow patterns normally associated with pro-thrombotic conditions such as decreased atrial function. 19 Diastolic dysfunction causes a decrease in stroke filling volume, 20 thereby potentially causing an insufficient perfusion in the coronary and brain vascular beds during exercise or similar episodes with increased oxygen demand. In addition, inadequate oxygen supply to the myocardium increase myocardial stiffness and LV end-diastolic pressure, 21 explaining how hypoxia may lead to diastolic dysfunction and is in turn worsened by diastolic dysfunction. In this study, the increased risk of ischaemic cardiovascular events was independent of the presence of AF, and the observed increased risk of re-infarction and stroke post-MI in heart failure patients 22 Characteristics differing between the two groups at the P , 0.1 level were included as covariates in the Cox models. BMI, body mass index; NYHA, New York heart association; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dysfunction; LAD, left atrial diameter; LA, left atrium; PCI, percutaneuos coronary intervention; CABG, coronary artery bypass grafting; LBBB, left bundle branch block; RBBB, right bundle branch block; ILR, implantable loop recorder; PM, pacemaker; ICD, implantable cardioverter defibrillator.
Diastolic dysfunction and age
Several of the echocardiographic parameters used to diagnose diastolic dysfunction, especially E ′ , DT, and E/A ratio, have all been shown to be highly dependent on age 23 and some suggest to adjust these measures by age. 24 However, as the risk of MI and stroke increases with age, and this increased risk has not been shown to be independent of the change in these echocardiographic parameters, we chose not to correct the cut-off values by, age but instead adjust for age in the multivariate Cox model. Interestingly, age did not show any correlation with the endpoint despite a significantly higher average age of patients in the group of patients with diastolic dysfunction. This may be due to the small sample size, but might also imply the different impact of these parameters in the study population of patients with known ischaemic heart disease and LV systolic dysfunction.
Limitations
The major limitation of this study is the small sample size which did not allow for a full multivariate adjustment. However, this is the first study to include measurement of diastolic dysfunction using tissue Doppler imaging and continuous monitoring with a device and the findings may well serve as a pilot for future studies in this high-risk population. Monitoring patients with an ILR has many advantages. The ILR can be implanted in patients without indication for device therapy and allows diagnosis of arrhythmias at low heart rates. On the other hand, the algorithms for diagnosis of arrhythmias are relying only on heart rate and the memory is limited. The ILR is capable of storing 13 events. If the memory is filled up before the device is interrogated, the earliest event is deleted if a new event is recorded. Also, the device was programmed to trigger on an average heart rate ≥125 bpm average over 16 beats. Thus, AF events occurring at heart rates below this has not been documented. However, due to the long and frequent follow-up in the study, we believe underreporting of AF to have a relatively low impact on the results. The echocardiography was performed 6 weeks post-MI to allow ventricular remodelling and functional stabilization after the AMI. However, a significant proportion of new-onset AF (38%) occurred within the first 6 weeks. Thus, future studies should investigate while earlier estimation of the LV diastolic function is prognostic for AF development.
Conclusions
Diastolic dysfunction in post-MI patients with moderate-to-severe LV systolic dysfunction predisposes to cardiovascular ischaemic events such as re-infarction and stroke. New-onset AF also occurs more frequently in patients with diastolic dysfunction. Re-infarction and stroke were more frequent in patients with newonset AF, but the increased risk of ischaemic events was independent of development of AF, suggesting that diastolic dysfunction in post-MI patients by itself is an important risk factor for ischaemic events. 
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